158P: PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin

E E C de Jong; W Van Elmpt; R T H Leijenaar; H Groen; E Smit; R Boellaard; V Van der Noort; E G C Troost; P Lambin; A-M Dingemans

doi:10.1016/S1556-0864(16)30268-4

158P: PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin

E E C de Jong, W Van Elmpt, R T H Leijenaar, H Groen, E Smit, R Boellaard, V Van der Noort, E G C Troost, P Lambin, A-M Dingemans

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	S126-7
Journal	Journal of Thoracic Oncology
Volume	11
Issue number	4 Suppl
DOIs	https://doi.org/10.1016/S1556-0864(16)30268-4
Publication status	Published - Apr 2016

Access to Document

10.1016/S1556-0864(16)30268-4

Cite this

Jong, E. E. C. D., Van Elmpt, W., Leijenaar, R. T. H., Groen, H., Smit, E., Boellaard, R., Noort, V. V. D., Troost, E. G. C., Lambin, P., & Dingemans, A-M. (2016). 158P: PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin. Journal of Thoracic Oncology, 11(4 Suppl), S126-7. https://doi.org/10.1016/S1556-0864(16)30268-4

@article{e2ef50065e74493eb7f987192b906cd6,

title = "158P: PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin",

keywords = "Journal Article",

author = "Jong, {E E C de} and {Van Elmpt}, W and Leijenaar, {R T H} and H Groen and E Smit and R Boellaard and Noort, {V Van der} and Troost, {E G C} and P Lambin and A-M Dingemans",

year = "2016",

month = apr,

doi = "10.1016/S1556-0864(16)30268-4",

language = "English",

volume = "11",

pages = "S126--7",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "International Association for the Study of Lung Cancer",

number = "4 Suppl",

}

Jong, EECD, Van Elmpt, W, Leijenaar, RTH, Groen, H, Smit, E, Boellaard, R, Noort, VVD, Troost, EGC, Lambin, P & Dingemans, A-M 2016, '158P: PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin', Journal of Thoracic Oncology, vol. 11, no. 4 Suppl, pp. S126-7. https://doi.org/10.1016/S1556-0864(16)30268-4

158P : PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin. / Jong, E E C de; Van Elmpt, W; Leijenaar, R T H et al.

In: Journal of Thoracic Oncology, Vol. 11, No. 4 Suppl, 04.2016, p. S126-7.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - 158P

T2 - PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin

AU - Jong, E E C de

AU - Van Elmpt, W

AU - Leijenaar, R T H

AU - Groen, H

AU - Smit, E

AU - Boellaard, R

AU - Noort, V Van der

AU - Troost, E G C

AU - Lambin, P

AU - Dingemans, A-M

PY - 2016/4

Y1 - 2016/4

KW - Journal Article

U2 - 10.1016/S1556-0864(16)30268-4

DO - 10.1016/S1556-0864(16)30268-4

M3 - Article

C2 - 27198295

SN - 1556-0864

VL - 11

SP - S126-7

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 4 Suppl

ER -